BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 14984739)

  • 1. Induction of lipolysis in vitro and loss of body fat in vivo by zinc-alpha2-glycoprotein.
    Russell ST; Zimmerman TP; Domin BA; Tisdale MJ
    Biochim Biophys Acta; 2004 Feb; 1636(1):59-68. PubMed ID: 14984739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of zinc-alpha2-glycoprotein (ZAG) on expression of uncoupling proteins in skeletal muscle and adipose tissue.
    Sanders PM; Tisdale MJ
    Cancer Lett; 2004 Aug; 212(1):71-81. PubMed ID: 15246563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the antiobesity effect of zinc-α2-glycoprotein in the ob/ob mouse.
    Russell ST; Tisdale MJ
    Int J Obes (Lond); 2011 Mar; 35(3):345-54. PubMed ID: 20697416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of glucocorticoids in the induction of zinc-alpha2-glycoprotein expression in adipose tissue in cancer cachexia.
    Russell ST; Tisdale MJ
    Br J Cancer; 2005 Mar; 92(5):876-81. PubMed ID: 15714206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasts between the effects of zinc-α2-glycoprotein, a putative β3/2-adrenoceptor agonist and the β3/2-adrenoceptor agonist BRL35135 in C57Bl/6 (ob/ob) mice.
    Wargent ET; O'Dowd JF; Zaibi MS; Gao D; Bing C; Trayhurn P; Cawthorne MA; Arch JR; Stocker CJ
    J Endocrinol; 2013 Feb; 216(2):157-68. PubMed ID: 23151357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc-α2-glycoprotein as a marker of fat catabolism in humans.
    Cabassi A; Tedeschi S
    Curr Opin Clin Nutr Metab Care; 2013 May; 16(3):267-71. PubMed ID: 23448999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc-alpha2-glycoprotein is involved in regulation of body weight through inhibition of lipogenic enzymes in adipose tissue.
    Gong FY; Zhang SJ; Deng JY; Zhu HJ; Pan H; Li NS; Shi YF
    Int J Obes (Lond); 2009 Sep; 33(9):1023-30. PubMed ID: 19621019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of eicosapentaenoic acid (EPA) on expression of a lipid mobilizing factor in adipose tissue in cancer cachexia.
    Russell ST; Tisdale MJ
    Prostaglandins Leukot Essent Fatty Acids; 2005 Jun; 72(6):409-14. PubMed ID: 15899583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia.
    Bing C; Bao Y; Jenkins J; Sanders P; Manieri M; Cinti S; Tisdale MJ; Trayhurn P
    Proc Natl Acad Sci U S A; 2004 Feb; 101(8):2500-5. PubMed ID: 14983038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients.
    Hirai K; Hussey HJ; Barber MD; Price SA; Tisdale MJ
    Cancer Res; 1998 Jun; 58(11):2359-65. PubMed ID: 9622075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc-alpha2-glycoprotein in cachexia and obesity.
    Tisdale MJ
    Curr Opin Support Palliat Care; 2009 Dec; 3(4):288-93. PubMed ID: 19823091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastrointestinal cancer patients.
    Mracek T; Stephens NA; Gao D; Bao Y; Ross JA; Rydén M; Arner P; Trayhurn P; Fearon KC; Bing C
    Br J Cancer; 2011 Feb; 104(3):441-7. PubMed ID: 21245862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [To burn or to store].
    Ricquier D
    Ann Endocrinol (Paris); 2002 Dec; 63(6 Pt 2):S7-14. PubMed ID: 12733325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent effects of an alpha2-adrenergic antagonist on lipolysis and thermogenesis: interactions with a beta3-adrenergic agonist in rats.
    Gómez-Ambrosi J; Frühbeck G; Aguado M; Milagro FI; Margareto J; Martínez AJ
    Int J Mol Med; 2001 Jul; 8(1):103-9. PubMed ID: 11408957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of β-adrenergic receptors in the anti-obesity and anti-diabetic effects of zinc-α2-glycoprotien (ZAG).
    Russell ST; Tisdale MJ
    Biochim Biophys Acta; 2012 Apr; 1821(4):590-9. PubMed ID: 22227600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the anti-obesity activity of zinc-α2-glycoprotein in the rat.
    Russell ST; Tisdale MJ
    Int J Obes (Lond); 2011 May; 35(5):658-65. PubMed ID: 20856251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased gene expression of brown fat uncoupling protein (UCP)1 and skeletal muscle UCP2 and UCP3 in MAC16-induced cancer cachexia.
    Bing C; Brown M; King P; Collins P; Tisdale MJ; Williams G
    Cancer Res; 2000 May; 60(9):2405-10. PubMed ID: 10811117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc-α2-glycoprotein: an adipokine modulator of body fat mass?
    Bing C; Mracek T; Gao D; Trayhurn P
    Int J Obes (Lond); 2010 Nov; 34(11):1559-65. PubMed ID: 20514048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into adipose tissue atrophy in cancer cachexia.
    Bing C; Trayhurn P
    Proc Nutr Soc; 2009 Nov; 68(4):385-92. PubMed ID: 19719894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a novel serum factor distinct from zinc alpha-2 glycoprotein that promotes body fat loss early in the development of cachexia.
    Byerley LO; Lee SH; Redmann S; Culberson C; Clemens M; Lively MO
    Nutr Cancer; 2010; 62(4):484-94. PubMed ID: 20432169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.